Innovation in life science can come in many forms but the fact that many such innovations involve the use of living organisms and/
or relate to how a doctor interacts with their patient means that protecting such innovation with patents can be controversial. As a
result, a number of legal restrictions have been put in place to limit patenting that are unique to the life science field. This guidance
note briefly considers the main restrictions in Europe and touches on related practices in the US.

This content is restricted to members. To view this content please register or login below to view this content.

Register to receive up-to-date information and advice on tax developments within your industry.